Shiraz E-Medical Journal

Published by: Kowsar

Hereditary of Alpha-1-Antitrypsin Deficiency

Sara Gholami 1 and Tayebeh Hamzehloei 1 , *
Authors Information
1 Department of Genetics, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • Shiraz E-Medical Journal: March 01, 2013, 14 (1); 63-75
  • Published Online: March 25, 2013
  • Article Type: Review Article
  • Received: December 24, 2012
  • Revised: January 20, 2012
  • Accepted: March 20, 2013

To Cite: Gholami S, Hamzehloei T. Hereditary of Alpha-1-Antitrypsin Deficiency, Shiraz E-Med J. 2013 ; 14(1):63-75.

Copyright © 2013, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Genetics
3. Clinical Manifestations
4. Determination of AAT Phenotypes
5. Molecular diagnosis of AATD
  • 1. Carrell R TJ. a1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci. 1985; : 463
  • 2. Eriksson S. Alpha-1-antitrypsin deficiency. J Hepatol. 1999; : 34-9
  • 3. MD Wewers MCSSSSKMJWRC. Replacement therapy deficiency associated with emphysema. N Engl J Med. 1987; (316): 1055-62
  • 4. Dry PJ. Rapid detection of alpha-1-antitrypsin deficiency by analysis of PCR-induced TaqI restriction site. Hum Genet. 1991; : 742-4
  • 5. G Vennarecci BGTISHBDKPMEE. Transplantation or end stage liver disease related to alpha-1-antitrypsin. Transplantation. 1996; : 1488-95
  • 6. De Tommaso AM, Rossi CL, Escanhoela CA, Serra HG, Bertuzzo CS, Hessel G. Diagnosis of alpha-1-antitrypsin deficiency by DNA analysis of children with liver disease . Arq Gastroenterol. 2001; : 63-38
  • 7. Janciauskiene S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim Biophys Acta. 2001; : 221-35
  • 8. RW Carrel . Alpha-1-antitrypsin: molecular pathology, leukocytes and tissue damage. J Clin Invest. 1986; : 1427-31
  • 9. Cox DW, Woo SL, Mansfield T. DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PI Z. Nature. 1985; : 79-81
  • 10. Hutchison DCS. < i> α</i>< sub> 1</sub>-Antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. Respiratory medicine. 1998; 92(3): 367-77
  • 11. Sveger T. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. New England J Med. 1976; 294(24): 1316-21
  • 12. O'Brien ML, Buist NRM, Murphey WH. Neonatal screening for alpha-1-antitrypsin deficiency. The Journal of pediatrics. 1978; 92(6): 1006-10
  • 13. Seixas S, Garcia O, Trovoada MJ, Santos MT, Amorim A, Rocha J. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum Genet. 2001; 108(1): 20-30[PubMed]
  • 14. Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. CHEST Journal. 1986; 89(3): 370-3
  • 15. Stoller JK, Smith P, Yang P, Spray J. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleveland Clinic journal of medicine. 1994; 61(6): 461
  • 16. Stoller JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C. Delay in Diagnosis of α1-Antitrypsin DeficiencyA Continuing Problem. CHEST Journal. 2005; 128(4): 1989-94
  • 17. Darlington GJ, Astrin KH, Muirhead SP, Desnick RJ, Smith M. Assignment of human alpha-1-antitrypsin to chromosome 14 by somatic cell hybrid analysis. Proc Nation Acad Sci. 1982; 79(3): 870-3
  • 18. DeMeo DL, Silverman EK. α1-Antitrypsin deficiency· 2: Genetic aspects of α1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax. 2004; 59(3): 259-64
  • 19. Sandhaus RA. α1-Antitrypsin deficiency· 6: New and emerging treatments for α1-antitrypsin deficiency. Thorax. 2004; 59(10): 904-9
  • 20. Li Y, Zhou L, Twining SS, Sugar J, Yue BY. Involvement of Sp1 elements in the promoter activity of the alpha1-proteinase inhibitor gene. J Biol Chem. 1998; 273(16): 9959-65[PubMed]
  • 21. Yamamoto Y, Sawa R, Okamoto N, Matsui A, Yanagisawa M, Ikemoto S. Deletion 14q(q24.3 to q32.1) syndrome: significance of peculiar facial appearance in its diagnosis, and deletion mapping of Pi(alpha 1-antitrypsin). Hum Genet. 1986; 74(2): 190-2[PubMed]
  • 22. Baumann H, Richards C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunology. 1987; 139(12): 4122-8
  • 23. Eriksson S, Alm R, Astedt B. Organ cultures of human fetal hepatocytes in the study of extra-and intracellular alpha1-antitrypsin. Biochim Biophys Acta. 1978; 542(3): 496-505[PubMed]
  • 24. Koj A, Regoeczi E, Toews CJ, Leveille R, Gauldie J. Synthesis of antithrombin III and alpha-1-antitrypsin by the perfused rat liver. Biochimica et Biophysica Acta (BBA)-General Subjects. 1978; 539(4): 496-504
  • 25. Cichy J, Potempa J, Travis J. Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells. J Biol Chem. 1997; 272(13): 8250-5[PubMed]
  • 26. Perlmutter DH, Daniels JD, Auerbach HS, De Schryver-Kecskemeti K, Winter HS, Alpers DH. The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem. 1989; 264(16): 9485-90[PubMed]
  • 27. Boskovic G, Twining SS. Local control of alpha1-proteinase inhibitor levels: regulation of alpha1-proteinase inhibitor in the human cornea by growth factors and cytokines. Biochim Biophys Acta. 1998; 1403(1): 37-46[PubMed]
  • 28. Kalsheker N, Morley S, Morgan K. Gene regulation of the serine proteinase inhibitors α1-antitrypsin and α1-antichymotrypsin. Biochemical Society Transactions. 2002; 30: 93-8
  • 29. Stoller JK, Snider GL, Brantly ML, Fallat RJ, Stockley RA, Turino GM, et al. American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. Pneumologie (Stuttgart, Germany). 2005; 59(1): 36
  • 30. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997; 75(5): 397-415[PubMed]
  • 31. Hay JG SMCR. Alpha1-antitrypsin gene and promoter. New York: Marcel Dekker Inc. 1996; : 21-31
  • 32. Carrell RW, Jeppsson JO, Vaughan L, Brennan SO, Owen MC, Boswell DR. Human alpha-1-antitrypsin: carbohydrate attachment and sequence homology. FEBS Lett. 1981; 135(2): 301-3[PubMed]
  • 33. Lomas DA. Molecular mousetraps, 1-antitrypsin deficiency and the serpinopathies. Clinical Medicine, Journal of the Royal College of Physicians. 2005; 5(3): 249-57
  • 34. Ljujic M, Topic A, Nikolic A, Divac A, Grujic M, Mitic-Milikic M, et al. Identification of a rare p.G320R alpha-1-antitrypsin variant in emphysema and lung cancer patients. Genet Mol Biol. 2010; 33(1): 5-8[DOI][PubMed]
  • 35. Lomas DA, Carrell RW. Serpinopathies and the conformational dementias. Nature Reviews Genetics. 2002; 3(10): 759-68
  • 36. Wood AM, Stockley RA. Alpha one antitrypsin deficiency: from gene to treatment. Respiration. 2007; 74(5): 481-92
  • 37. Parfrey H, Mahadeva R, Lomas DA. Alpha(1)-antitrypsin deficiency, liver disease and emphysema. Int J Biochem Cell Biol. 2003; 35(7): 1009-14[PubMed]
  • 38. Frazier GC, Siewertsen MA, Hofker MH, Brubacher MG, Cox DW. A null deficiency allele of alpha 1-antitrypsin, QOludwigshafen, with altered tertiary structure. J Clin Invest. 1990; 86(6): 1878-84[DOI][PubMed]
  • 39. Vidal R, Blanco I, Casas F, Jardí R, Miravitlles M. Committee on the National Registry of Individuals with Alpha-1 Antitrypsin Deficiency.[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency][Article in Spanish]. Arch Bronconeumol. 2006; 42(12): 645-59
  • 40. Schlade-Bartusiak K, Cox DW. Alpha1-antitrypsin deficiency. GeneReviews [Internet]. Seattle (WA). University of Washington, Seattle. 2006;
  • 41. Fregonese L, Stolk J. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008; 3: 16
  • 42. Carlson JA, Rogers RB, Sifers R. Acumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest . 1989; : 1183-90
  • 43. Lomas DA. The selective advantage of α1-antitrypsin deficiency. American journal of respiratory and critical care medicine. 2006; 173(10): 1072-7
  • 44. Sivasothy P, Dafforn TR, Gettins PG, Lomas DA. Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J Biol Chem. 2000; 275(43): 33663-8[DOI][PubMed]
  • 45. JO Jeppsson CLMF. Properties of isolated alpha-1- antitrypsin of Pi types M, S and Z. Eur J Biochem . 1978; : 143-53
  • 46. Gooptu B, Hazes B, Chang WSW, Dafforn TR, Carrell RW, Read RJ, et al. Inactive conformation of the serpin α1-antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease. Proceedings of the National Academy of Sciences. 2000; 97(1): 67-72
  • 47. Camelier AA, Winter DH, Jardim JR, Barboza CEG, Cukier A, Miravitlles M. Deficiência de alfa-1 antitripsina: diagnóstico e tratamento. J Bras Pneumol. 2008; 34(7): 514-27
  • 48. Kopito RR, Ron D. Conformational disease. Nat Cell Biol. 2000; 2(11)-9[DOI][PubMed]
  • 49. Dafforn TR, Mahadeva R, Elliott PR, Sivasothy P, Lomas DA. A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem. 1999; 274(14): 9548-55[PubMed]
  • 50. Mahadeva R, Lomas DA. Alpha1-antitrypsin deficiency, cirrhosis and emphysema. Thorax. 1998; 53(6): 501-5
  • 51. Carrell RW, Lomas DA. Alpha-1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med. 2002; 346(1): 45-53[DOI][PubMed]
  • 52. Brantly M, Nukiwa T, Crystal RG. Molecular basis of alpha-1-antitrypsin deficiency. Am J Med. 1988; 84(6A): 13-31[PubMed]
  • 53. Sveger T, Eriksson S. The liver in adolescents with alpha-1-antitrypsin deficiency. Hepatology. 1995; 22(2): 514-7[PubMed]
  • 54. Granell S, Baldini G, Mohammad S, Nicolin V, Narducci P, Storrie B. Sequestration of mutated alpha1-antitrypsin into inclusion bodies is a cell-protective mechanism to maintain endoplasmic reticulum function. Mol Biol Cell. 2008; 19(2): 572-86[DOI][PubMed]
  • 55. Carlson JA, Rogers BB, Sifers RN, Finegold MJ, Clift SM, DeMayo FJ, et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. Journal of Clinical Investigation. 1989; 83(4): 1183
  • 56. Perlmutter DH. Liver injury in α1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. Journal of Clinical Investigation. 2002; 110(11): 1579
  • 57. Greene CM, Miller SDW, Carroll T, McLean C, O’Mahony M, Lawless MW, et al. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J Inherit Metabol Dis. 2008; 31(1): 21-34
  • 58. Werner ED, Brodsky JL, McCracken AA. Proteasome-dependent endoplasmic reticulum-associated protein degradation: an unconventional route to a familiar fate. Proc National Academy Sci. 1996; 93(24): 13797-801
  • 59. Cabral CM, Liu Y, Moremen KW, Sifers RN. Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs. Mol biol Cell. 2002; 13(8): 2639-50
  • 60. Sifers RN. Insights into checkpoint capacity. Nature structural & molecular biology. 2004; 11(2): 108-9
  • 61. Kelly E, Greene CM, Carroll TP, McElvaney NG, O'Neill SJ. Alpha-1 antitrypsin deficiency. Respiratory medicine. 2010; 104(6): 763-72
  • 62. Hidvegi T, Schmidt BZ, Hale P, Perlmutter DH. Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and -12, NFkappaB, and BAP31 but not the unfolded protein response. J Biol Chem. 2005; 280(47): 39002-15[DOI][PubMed]
  • 63. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003; 168(7): 818-900[DOI][PubMed]
  • 64. Kramps JA, Bakker W, Dijkman JH. A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency. Am Rev Respir Dis. 1980; 121(2): 253-61[PubMed]
  • 65. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005; 365(9478): 2225-36[DOI][PubMed]
  • 66. Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Kohnlein T, Welte T. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med. 2011; 105(8): 1129-39[DOI][PubMed]
  • 67. DOWSON LEEJ, GUEST PJ, STOCKLEY RA. Longitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with decline. American journal of respiratory and critical care medicine. 2001; 164(10): 1805-9
  • 68. Vidal R, Blanco I, Casas F, Jardí R, Miravitlles M. Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]. Archivos de bronconeumología. 2006; 42(12): 645
  • 69. Schwartz M, Petersen KB, Gregersen N, Hinkel K, Newton CR. Prenatal diagnosis of alpha-1-antitrypsin deficiency using polymerase chainreaction (PCR). Comparison of conventional RFLP methods with PCR used in combination with allelespecific oligonucleotides or RFLP analysis. Clinical genetics. 1989; 36(6): 419-26
  • 70. Hogarth DK, Rachelefsky G. Screening and familial testing of patients for α1-antitrypsin deficiency. CHEST Journal. 2008; 133(4): 981-8
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments